Aeterna Zentaris
AEZS
#10377
Rank
A$24.93 M
Marketcap
A$8.14
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.92. In 2022 the company made an earnings per share (EPS) of A-$6.66 a decrease over its 2021 EPS that were of A-$2.59.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.66157.14%
2021A-$2.59-41.48%
2020A-$4.43-64.46%
2019A-$12.46-240%
2018A$8.90-122.32%
2017A-$39.87-53.53%
2016A-$85.78-86.71%
2015A-$645.69-35.21%
2014A-$996.66-216.67%
2013A$854.28-123.3%
2012A-$3,666-40.8%
2011A-$6,194-6.45%
2010A-$6,621-27.91%
2009A-$9,183-61.61%
2008A-$23,92083.61%
2007A-$13,028-195.31%
2006A$13,668178.26%
2005A$4,912-330%
2004A-$2,136-80.05%
2003A-$10,70517.78%
2002A-$9,089515.93%
2001A-$1,476-68.6%
2000A-$4,700119.62%
1999A-$2,140-3.63%
1998A-$2,221

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.00-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$3.64-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.07-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$3.72-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA